DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0497327 | Dementia | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0079731 | B-Cell Lymphomas | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0023434 | Chronic Lymphocytic Leukemia | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C1527390 | Neoplasms, Intracranial | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0011570 | Mental Depression | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0036341 | Schizophrenia | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0023418 | leukemia | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C1332986 | Childhood Osteosarcoma | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0030297 | Pancreatic Neoplasm | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C1168401 | Squamous cell carcinoma of the head and neck | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C1263858 | Muscular dystrophy congenital, merosin negative | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0279070 | Adult Oligodendroglioma | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0009319 | Colitis | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0011265 | Presenile dementia | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0029463 | Osteosarcoma | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0029408 | Degenerative polyarthritis | CSPG4 | 1464 | chondroitin sulfate proteoglycan 4 | Q6UVK1 |
C0026769 | Multiple Sclerosis | CSGALNACT2 | 55454 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | Q8N6G5 |
C0003850 | Arteriosclerosis | CSGALNACT2 | 55454 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | Q8N6G5 |
C0019569 | Hirschsprung Disease | CSGALNACT2 | 55454 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | Q8N6G5 |
C0699790 | Colon Carcinoma | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0007102 | Malignant tumor of colon | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0025202 | melanoma | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0018378 | Guillain-Barre Syndrome | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
C0026769 | Multiple Sclerosis | CSGALNACT1 | 55790 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Q8TDX6 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024